A Comparison of Clinical Profile and Treatment Outcome of Hodgkin’s Lymphoma in Tanzania According to HIV Status during the HAART era

Author:

Mbai Mercy M1,Md Emmanuel2,Thuo Samuel1,Rugengamanzi Eulad1,Malichewe Christina V1,Lugina Emmanuel L.1

Affiliation:

1. Muhimbili University of Health and Allied Sciences

2. Rabininsia Memorial Hospital

Abstract

Abstract Background The incidence of Hodgkin’s lymphoma (HL) in HIV-positive individuals is approximately 19X more than in HIV-negative persons. Most HIV-HL patients present at an advanced stage (Ann Arbor stage III-IV), have “B” symptoms and extranodal involvement. HAART's development has led to a significant change in the natural history and risk stratification of HIV-HL. Therefore, this study aimed to determine differences in clinicopathological and survival patterns of HL among individuals with and without HIV disease in Tanzania in the HAART era. Methodology This hospital-based retrospective cohort study was conducted at the ORCI, Dar-Es-Salaam, Tanzania. Chi-square and Fisher’s exact tests were used to compare proportions. Student t-test was used to compare means. The log-rank test was applied to the variables in univariate analysis to identify factors that predict survival. The factors that were significant in univariate analysis were then analyzed in multivariate fashion using a Cox regression model. Results 83 patients with HL were recruited, and the prevalence of HIV-positive status was 27.7%. Most of the patients with HIV-HL had an age of more than 30 years (73.9%), while most of the non-HIV-HL patients had an age of less than 30 years (63.3%) (P = 0.02). The 2-year OS rate for HIV-HL was 34%, while that for non-HIV-HL was 67%. Among the HIV-HL patients, predictors of a poorer outcome were a CD4 count ≤ 200 cells/mm3 (P = 0.05), lack of HAART use (P = 0.00), and the use of HAART for ≤ 10 months (P = 0.00). Conclusion The prevalence of HIV-HL was 27.7% among HL patients. HIV positivity is still a poor prognostic factor in our setting, especially for patients not on HAART, on HAART for less than ten or ten months, or with a low CD4 count below 200 cells/mm3.Patients with HIV-HL were older and had higher LDH levels, whereas patients with non-HIV-HL were younger and had low LDH levels.

Publisher

Research Square Platform LLC

Reference20 articles.

1. Hodgkin’s lymphoma: The pathologist’s viewpoint;Pileri SA;J Clin Pathol,2002

2. Globocan. 2020. Hodgkin lymphoma wordwide. 2020.

3. Globocan. 2020. Tanzania, United Republic of. 2021.

4. Y.Taoufik DC. High risk features contrast with favorable outcomes in HIV-associated Hodgkin Lymphoma in the modern cART era, ANRS CO16 LYMPHOVIR cohort;C.Besson R;Clin Infect Dis,2015

5. Prevalence of HIV infection among U.S. hodgkin lymphoma cases;Shiels MS;Cancer Epidemiol Biomarkers Prev,2014

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3